the web. >>

bookmark our new home on

behind. Stay Connected and

We're moving. Don't get left

our new home on the web. >>

collateral, and resources at

MPI services, content,

River. Find information about

MPI is now a part of Charles

email newsletter. >>

Sign up today to recieve our

to the Charles River family.

MPI services as we transition

and information about

Don't miss the latest news

and support at our new home on the web.

Explore our portfolio of expanded services

MPI has joined the Charles River family

Welcome to MPI Research2018-08-16T13:29:39+00:00

MPI Research strives to be the best CRO in preclinical contract research.

Read More

Read the latest from our experts!

Watch Now

Listen to Chris Dillon as he examines the importance of animal welfare as it relates to drug development factors.

Watch Now

SEND requirements are now in effect and many companies have implementation questions: Is SEND required for this study?

We are committed to bring safer and more effective drugs and devices to the market faster and more efficiently.

With over 32,000 studies and counting and high satisfaction, MPI Research aims to be the CRO partner for your drug and device programs.

We partner with Sponsors around the world to develop their drug and device programs. Every year, our experienced scientists and dedicated technical team conduct thousands of discovery, drug safety, bioanalytical, analytical, and medical device studies.

Submit Inquiry
IND-enabling Packages
Conducted Annually
People Dedicated to
Improving Healthcare

“MPI Research was very impressive, perhaps one of the best CROs I’ve seen! This company is proof that proper procedures and systems can be put in place for compliance; they have all the key SOPs and systems in place (and then some) that I look for. I only wish that I could take MPI Research with me as an example for other companies and CROs. The personnel were very helpful and knowledgeable; I would recommend this company to any one of my clients needing these services.”

Denise Carpenter,
Owner and President D.A. Carpenter Consulting, Inc.

“I was very impressed with the MPI Research team’s care in animal handling and their established enrichment programs for our various carcinogenicity studies. I continue to share the excellence of their animal care programs with our partners and other CROs. I would like to thank all the team members involved in our studies for taking such great care of the animals.”

Executive Director,
Pharmaceutical Company

“We have developed an extremely productive partnership with MPI Research over the past several years. Through the many immunology, pharmacokinetic, and general toxicology studies we have conducted at MPI Research, we have received quality, on-time data that has allowed us to progress our compounds along the drug development pathway. We trust and appreciate the commitment to excellence and dedication of MPI Research and we look forward to expanding our partnership.”

Chief Scientific Officer,
Biotechnology Company

Let us take you further